protein 623 words KG: KDM5APROTEIN 2026-03-21
kind:proteinsection:proteinsstate:published
Contents

KDM5A Protein (Lysine Specific Demethylase 5A (JARID1A))

🔬 Protein Info
Gene SymbolKDM5A
Full NameLysine Specific Demethylase 5A
AliasesLysine Specific Demethylase 5A (JARID1A
Chromosome12p13.33
Protein FamilyJARID1 family (Jumonji C domain demethylase)
FunctionThis activity positions KDM5A as a transcriptional repressor that silences gene expression programs [[klose2006]](https://pubmed.ncbi.nlm.nih.gov/17110336/).
PathwaysDevelopmental Gene Regulation, Developmental Regulation
UniProt IDQ9UMM3
NCBI Gene ID8248
Ensembl IDENSG00000150109
OMIM180388
GeneCardsKDM5A
Human Protein AtlasKDM5A
KDM5B/JARID1BRelated demethylase with overlapping substrate specificity
Histone ModificationsH3K4 methylation and chromatin architecture
Associated DiseasesALS, Aging, Diabetes, Ferroptosis
InteractionsPARP1, AND, NURD COMPLEX, CHD4
KG Connections40 knowledge graph edges
DatabasesGeneCardsHPASTRING

Knowledge Graph

Related Hypotheses (5)

Bacterial Enzyme-Mediated Dopamine Precursor Synthesis
Score: 0.36
Heat Shock Protein 70 Disaggregase Amplification
Score: 0.51
Serine/Arginine-Rich Protein Kinase Modulation
Score: 0.42
Grid Cell-Specific Metabolic Reprogramming via IDH2 Enhancem
Score: 0.38
Designer TRAK1-KIF5 fusion proteins accelerate therapeutic m
Score: 0.35

Related Analyses (11)

TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived
Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived
4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived
Protein aggregation cross-seeding across neurodegenerative d
neurodegeneration · archived

Related Experiments (12)

Animal Model Comparison for Neurodegenerative Disease Therap
clinical · proposed · Score: 0.40
Endocannabinoid System Dysfunction Validation in Parkinson's
clinical · proposed · Score: 0.40
Glymphatic-Circadian Axis Enhancement Therapy for Parkinson'
clinical · proposed · Score: 0.40
Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag
clinical · proposed · Score: 0.40
Neural Oscillation Dysfunction Validation in Parkinson's Dis
clinical · proposed · Score: 0.40

See Also (1)

Neurodegeneration
disease · KG edge: implicated_in